All of us at Oncology Practice Management are delighted to offer the Eighth Annual Oncology Guide to Patient Support Services. At the time of publishing, the Guide represents a comprehensive list of all pharma-sponsored oncology patient support programs. It is our sincere hope the Guide will assist you in enrolling your patients in the programs that can help easy some of the burden of their cancer journey.
In response to the challenges patients face when diagnosed with cancer, pharmaceutical companies have created robust support programs in the hope of offering meaningful help to the patients who are prescribed their products. However, many times, healthcare providers and patients are unaware of the abundant services offered by pharma companies. After making the diagnosis and selecting the best treatment, take one more step by prescribing a support program for your patient. Enrolling your patient in a pharma-sponsored support program can help to ease some of the burden they will face while undergoing treatment.
Services will vary from company to company, but in general, each program aims to provide access to their medicine, education about the disease and the prescribed treatment, and emotional support for the patient. Pharma-sponsored support programs may include services such as:
There are also services to help you and your office staff, such as benefit verification, insurance coverage determination, prior authorizations, and claims/appeals support.
In these pages, you will find patient support programs organized by company name and the services each program offers. A list by drug name is included in the index.
We encourage all oncology healthcare providers to use the Guide and share this information with patients. We hope the Guide proves to be a useful tool to you in your practice.
EDITOR’S NOTE: The company profiles in this Guide are based on information posted online by the respective pharmaceutical companies as of December 2021. Every effort has been made to verify the information up to that time. Any updates, including new drugs approved after that time, will not appear in this publication. The Publisher and the Editors are not responsible for any inaccuracies stemming from changes, new drug approvals, or company updates that became available later. Readers are advised to review the websites of each drug company for any updates and revisions.